The novel gaseous vasorelaxant hydrogen sulfide inhibits angiotensin-converting enzyme activity of endothelial cells

Journal of Hypertension

Volumn 25, Issue 10, 2007, Pages 2100-2104

  Laggner, Hilde ^a   Hermann, Marcela ^b   Esterbauer, Harald ^a   Muellner, Markus K ^a   Exner, Markus ^a,d   Gmeiner, Bernhard M K ^a   Kapiotis, Stylianos ^a,c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c Hospital of the Divine Redeemer   (Austria)

^d Laboratorium Dr Johannes Bauer   (Austria)

Author keywords

Angiotensin converting enzyme; Endothelial cells; Hydrogen sulfide

Indexed keywords

ANGIOTENSIN II; BRADYKININ; CADMIUM; CALCIUM; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROGEN SULFIDE; MAGNESIUM; MESSENGER RNA; PROTEIN DERIVATIVE; VASODILATOR AGENT; ZINC;

ARTICLE; CELL CULTURE; CELL SURFACE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; EX VIVO STUDY; GAS; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL VEIN; VASODILATATION;

EID: 34748855638     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32829b8fd0     Document Type: Article

References (32)

1. 2S be the third endogenous gaseous transmitter? FASEB J 2002; 16:1792-1798.
2. Moore PK, Bhatia M, Moochhala S. Hydrogen sulfide: from the smell of the past to the mediator of the future? Trends Pharmacol Sci 2003; 24:609-611.
3. Li L, Bhatia M, Moore PK. Hydrogen sulphide - a novel mediator of inflammation? Curr Opin Pharmacol 2006; 6:125-129.
4. Bian JS, Yong QC, Pan TT, Feng ZN, Ali MY, Zhou S, et al. Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes. J Pharmacol Exp Ther 2006; 316:670-678.
5. Pan TT, Feng ZN, Lee SW, Moore PK, Bian JS. Endogenous hydrogen sulfide contributes to the cardioprotection by metabolic inhibition preconditioning in the rat ventricular myocytes. J Mol Cell Cardiol 2006; 40:119-130.
6. Bukovska G, Kery V, Kraus JP. Expression of human cystathionine beta-synthase in Escherichia coli: purification and characterization. Protein Expr Purif 1994; 5:442-448.
7. Erickson PF, Maxwell IH, Su LJ, Baumann M, Glode LM. Sequence of cDNA for rat cystathionine gamma-lyase and comparison of deduced amino acid sequence with related Escherichia coli enzymes. Biochem J 1990; 269:335-340.
8. Zhao W, Zhang J, Lu Y, Wang R. The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener. EMBO J 2001; 20:6008-6016.
9. Bhatia M. Hydrogen sulfide as a vasodilator. IUBMB Life 2005; 57:603-606.
10. Hosoki R, Matsuki N, Kimura H. The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Commun 1997; 237:527-531.
11. Dzau VJ. Significance of the vascular renin-angiotensin pathway. Hypertension 1986; 8:553-559.
12. Unger T. The role of the renin-angiotensin system in the development of cardiovascular disease. Am J Cardiol 2002; 89:3A-9A.
13. Wei L, Alhenc-Gelas F, Corvol P, Clauser E. The two homologous domains of human angiotensin I-converting enzyme are both catalytically active. J Biol Chem 1991; 266:9002-9008.
14. Ryan JW, Ryan US, Schultz DR, Whitaker C, Chung A. Subcellular localization of pulmonary antiotensin-converting enzyme (kininase II). Biochem J 1975; 146:497-499.
15. Caldwell PR, Seegal BC, Hsu KC, Das M, Soffer RL. Angiotensin-converting enzyme: vascular endothelial localization. Science 1976; 191:1050-1051.
16. 3H]benzoyl- phenylalanylalanyl-proline by pulmonary angiotensin converting enzyme in vivo: effects of bradykinin, SQ 14225 or acute hypoxia. J Pharmacol Exp Ther 1981; 217:263-270.
17. Bernstein KE, Xiao HD, Frenzel K, Li P, Shen XZ, Adams JW, et al. Six truisms concerning ACE and the renin-angiotensin system deduced from the genetic analysis of mice. Circ Res 2005; 96:1135-1144.
18. Riordan JF. Angiotensin-I-converting enzyme and its relatives. Genome Biol 2003; 4:225-229.
19. Kohlstedt K, Brandes RP, Muller-Esterl W, Busse R, Fleming I. Angiotensin-converting enzyme is involved in outside-in signaling in endothelial cells. Circ Res 2004; 94:60-67.
20. Kohlstedt K, Busse R, Fleming I. Signaling via the angiotensin-converting enzyme enhances the expression of cyclooxygenase-2 in endothelial cells. Hypertension 2005; 45:126-132.
21. Fleming I, Kohlstedt K, Busse R. New fACEs to the renin-angiotensin system. Physiology (Bethesda) 2005; 20:91-95.
22. Kohlstedt K, Kellner R, Busse R, Fleming I. Signaling via the angiotensin-converting enzyme results in the phosphorylation of the nonmuscle myosin heavy chain IIA. Mol Pharmacol 2006; 69:19-26.
23. Sturrock ED, Natesh R, van Rooyen JM, Acharya KR. Structure of angiotensin I-converting enzyme. Cell Mol Life Sci 2004; 61:2677-2686.
24. Smith RP, Abbanat RA. Protective effect of oxidized glutathione in acute sulfide poisoning. Toxicol Appl Pharmacol 1966; 9:209-217.
25. Park CM, Nagel RL, Blumberg WE, Peisach J, Magliozzo RS. Sulfhemoglobin. Properties of partially sulfurated tetramers. J Biol Chem 1986; 261:8805-8810.
26. Kapiotis S, Besemer J, Bevec D, Valent P, Bettelheim P, Lechner K, et al. Interleukin-4 counteracts pyrogen-induced downregulation of thrombomodulin in cultured human vascular endothelial cells. Blood 1991; 78:410-415.
27. Balyasnikova IV, Danilov SM, Muzykantov VR, Fisher AB. Modulation of angiotensin-converting enzyme in cultured human vascular endothelial cells. In Vitro Cell Dev Biol Anim 1998; 34:545-554.
28. Rozen S, Skaletsky HJ. Primer3 on the WWW for general users and for biologist programmers. In: Krawetz S, Misener S, editors. Bioinformatics methods and protocols: Methods in molecular biology. Totowa, NJ: Humana Press; 2000. pp. 365-386.
29. Qu K, Chen CP, Halliwell B, Moore PK, Wong PT. Hydrogen sulfide is a mediator of cerebral ischemic damage. Stroke 2006; 37:889-893.
30. Stuhlsatz HW. Aminosäuren Stoffwechsel. In: Gressner AM, editor. Lehrbuch der Klinischen Chemie und Pathobiochemie. Stuttgart, New York: Schattauer; 1995. pp. 362-391.
31. 2S on human aorta smooth muscle cells. FASEB J 2006; 20:553-555.
32. Abe K, Kimura H. The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci 1996; 16:1066-1071.